Abstract:English: We identified that inhibition of EndoG in cardiomyocytes resulted in an increase in cell size, hypertrophic biomarkers and ROS in the absence of pro-hypertrophic stimulation. We also observed that EndoG deleted mouse heart established lipid-like droplets associated with mitochondira were more numerous and larger than wt, which were proved to be steatosis according to Oil Red O staining and molecular studies. During cardiac hypertrophy, we found hypertrophic agonist stimulation increased Mef2 expression by enhancing its translation. MEF2 abundance was increased by Calcineurin overexpression in vivo and was reduced by Calcineurin inhibition in vitro, without affecting Mef2 mRNA levels. Calcineurin activity influenced expression of PTB, contributing to MEF2 translation. Our results showed HDAC5-deficient mice had reduced cardiac PTB protein abundance and HDAC inhibition caused caspase-dependent cleavage of PTB protein abundance and a reduction in endogenous expression of cFLIP in myocytes. Cardiac PTB expression was abnormally high in mice with cardiac-specific caspase deficient, and cFLIP overexpression prevented PTB cleavage in vitro. Initial cleavage triggered further fragmentation of PTB and fragments accumulated in the presence of proteasome inhibitors. Experimental modification of the above process in vivo and in votro resulted in coherent changes in the splicing of MEF2's exons. Spanish: Se identifico que la inhibicion de EndoG en cardiomiocitos como resultado un aumento en el tamano celular, los biomarcadores hipertroficas y ROS en ausencia de pro-hipertrofica estimulacion. Tambien se observo que EndoG corazon eliminada raton establecido como gotitas de lipidos asociados con mitochondira eran mas numerosos y mas grande que en peso, que se demostro ser esteatosis de acuerdo con Oil Red O tincion y los estudios moleculares. Durante la hipertrofia cardiaca, encontramos la estimulacion agonista hipertrofica aumentado MEF2 expresion mediante la mejora de su traduccion. MEF2 abundancia se incremento por la sobreexpresion de calcineurina in vivo y se redujo por inhibicion de la calcineurina in vitro, sin afectar a los niveles de mRNA MEF2. Actividad de la calcineurina influenciado expresion de parto prematuro, lo que contribuye a MEF2 traduccion. Nuestros resultados mostraron HDAC5 ratones deficientes habia reducido abundancia cardiaco proteina PTB y la inhibicion de HDAC causado dependiente de caspasa escision de la abundancia de proteinas PTB y una reduccion en la expresion endogena de cFLIP en miocitos. Cardiac expresion PTB fue anormalmente elevada en ratones con enfermedad cardiaca especifica de la caspasa deficiente, y la sobreexpresion cFLIP impide la escision PTB in vitro. Escision inicial desencadena una mayor fragmentacion de PTB y fragmentos acumulados en la presencia de inhibidores del proteasoma. Experimental modificacion del procedimiento anterior in vivo e in votro resulto en cambios coherentes en el empalme de exons de MEF2. Catalan: Es va identificar que la inhibicio de AIF en cardiomiocits com a resultat un augment en la grandaria cel·lular, els biomarcadors hipertrofiques i ROS en absencia de pro-hipertrofica estimulacio. Tambe es va observar que AIF cor eliminada ratoli establert com gotetes de lipids associats amb mitochondira eren mes nombrosos i mes gran que en pes, que es va demostrar ser esteatosi d'acord amb Oil Red O tincio i els estudis moleculars. Durant la hipertrofia cardiaca, trobem l'estimulacio agonista hipertrofica augmentat MEF2 expressio mitjancant la millora de la seva traduccio. MEF2 abundancia es va incrementar per la sobreexpressio de calcineurina in vivo i es va reduir per inhibicio de la calcineurina in vitro, sense afectar els nivells de mRNA MEF2. Activitat de la calcineurina influenciat expressio de part prematur, el que contribueix a MEF2 traduccio. Els nostres resultats van mostrar HDAC5 ratolins deficients havia reduit abundancia cardiac proteina PTB i la inhibicio de HDAC causat dependent de caspasa escissio de l'abundancia de proteines PTB i una reduccio en l'expressio endogena de cFLIP en miocits. Cardiac expressio PTB va ser anormalment elevada en ratolins amb malaltia cardiaca especifica de la caspasa deficient, i la sobreexpressio cFLIP impedeix l'escissio PTB in vitro. Escissio inicial desencadena una major fragmentacio de PTB i fragments acumulats en la presencia d'inhibidors del proteasoma. Experimental modificacio del procediment anterior in vivo i in votro resultar en canvis coherents en l'entroncament de exons de MEF2.

Identification of Novel Signaling Pathways for Cardiomyocyte Differentiation and Growth

A Pathway Involving HDAC5, Cflip and Caspases Regulates Expression of the Splicing Regulator Polypyrimidine Tract Binding Protein in the Heart.

Translation of Myocyte Enhancer Factor-2 is Induced by Hypertrophic Stimuli in Cardiomyocytes Through a Calcineurin-dependent Pathway.

Cellular repressor of E1A-stimulated genes attenuates cardiac hypertrophy and fibrosis.

Cardiac-Specific Overexpression of ERRγ in Mice Induces Severe Heart Dysfunction and Early Lethality

GATA3 Promotes the Autophagy and Activation of Hepatic Stellate Cell in Hepatic Fibrosis Via Regulating Mir-370/Hmgb1 Pathway.

Inhibition of Mitofusin-2 Promotes Cardiac Fibroblast Activation via the PERK/ATF4 Pathway and Reactive Oxygen Species

Deletion of delta-like 1 homologue accelerates fibroblast–myofibroblast differentiation and induces myocardial fibrosis

Myocardial Overexpression of Mecr, A Gene of Mitochondrial Fas Ii Leads to Cardiac Dysfunction in Mouse

Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy

Abstract P1026: Creg1 Inhibits Cardiomyocyte Proliferation And Promotes Myocardial Differentiation And Compaction During Postnatal Cardiac Development

Prohibitin 1 deletion from activated cardiac fibroblasts in vivo attenuates cardiac fibrosis

A cardiac fibrosis determinative factor, Meox1, blocks direct reprogramming of cardiac myofibroblasts to cardiomyocyte-like cells

Cip, A Cardiac Isl1-Interacting Protein, Represses Cardiomyocyte Hypertrophy

Selective enhancement of cardiomyocyte efficiency results in a pernicious heart condition

Cardiomyocyte-restricted High-Mobility Group Box 1 (HMGB1) Deletion Leads to Small Heart and Glycolipid Metabolic Disorder Through GR/PGC-1α Signalling

Regulation of cardiac fibrosis in mice with TAC/DOCA‐induced HFpEF by resistin‐like molecule gamma and adenylate cyclase 1

Targeting Mef2 Acetylation Improves Myocardial Recovery And Overall Survival In Mice

Myocyte-specific Enhancer Factor 2C: a Novel Target Gene of Mir-214-3p in Suppressing Angiotensin II-induced Cardiomyocyte Hypertrophy.

Efectos Antiaterogénicos De La Inhibición De La Expresión De MCP-1 Mediada Por ARNi

Abstract 19295: Genetic Deletion of E2F1 Protects Myocardium from Ischemic Injury by Upregulating Angiogenic Growth Factors